COVID-19 UPDATE: Technology/Growth need favorable outcomes on 5 of 5 "wall of worries" to avoid further downside...

Click HERE to access the FSInsight COVID-19 Daily Chartbook.

We are shifting to a 4-day a week publication schedule:

  • Monday
  • Tuesday
  • Wednesday
  • SKIP THURSDAY
  • Friday

STRATEGY:  Headwinds for Technology might be reaching "break point" (to downside)
The FDA approved the Pfizer vaccine for use with kids age 12 to 15.  This move, while expected and not entirely surprising, still moves the ball forward in the fight against COVID-19.  

- in late March, Pfizer/BioNTech noted their study showed vaccine 100% effective for adolescents
- there are 17 million kids age 12 to age 15, or 6% of the population
- even younger Americans could get vaccinated by the Fall

Thus, by expanding vaccinations, the US addressable market for vaccine penetration has increased substantially

The video in this report is only accessible to members
Source: https://www.cnbc.com/2021/05/10/pfizer-covid-vaccine-fda-clears-use-in-kids-ages-12-to-15.htmlThe trends in US COVID-19 cases remains positive and we expect US cases to fall sub-20,000 next week.  In fact, next Sunday, this figure could possible be sub-10,000.  But to appreciate the dwindling risks of COVID-19 across the US, take a look at the positivity rate:- 7D positivity rate is 3.3%- this is an all-time low since the start of the pandemic- yup, it’s never been lowerThat ...

Unlock this article with a FREE 30-Day Trial!

An FSI Pro, or FSI Macro subscription is required in order to access this content.

*Free trial available only on a monthly plan

More from the author

Disclosures (show)

Get invaluable analysis of the market and stocks. Cancel at any time. Start Free Trial

Articles Read 2/2

🎁 Unlock 1 extra article by joining our Community!

You’ve reached your limit of 2 free monthly articles. Please enter your email to unlock 1 more articles.

Already have an account? Sign In

Don't Miss Out
First Month Free